Approvals/TGA/EUG-IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Approved

STANDARD

EUG-IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Eugia Pharma (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f7a4789e550025ac
Product Name: EUG-IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Artg Id: 439199
Artg Name: EUG-IRINOTECAN irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Sponsor: Eugia Pharma (Australia) Pty Ltd
Company Detail Path: /organization/eugia-pharma-australia-pty-ltd
Artg Date: 2025-03-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

f7a4789e550025ac

Type

Standard